Qin Qiong
Associate Chief Pharmacist and Lecturer, Department of Pharmacy
The First Affiliated Hospital of Soochow University
E-mail: q-q2456@163.com
Biography:
Qin Qiong is a doctoral candidate and a clinical pharmacist in the Department of Cardiovascular Surgery at the First Affiliated Hospital of Soochow University. In 2018, she completed standardized training as a clinical pharmacist in anticoagulation therapy at the First Affiliated Hospital of Sun Yat-sen University, and in 2022, she completed faculty training for clinical pharmacists at Shanghai Changhai Hospital. She is currently a national clinical pharmacist training instructor for anticoagulation therapy and a certified pharmacist in Therapeutic Drug Management (MTM) by the China Pharmaceutical University. Her work focuses on comprehensive pharmaceutical care and the rational use of anticoagulant drugs. Her main research directions include clinical pharmacy and individualized treatment, as well as gut microbiota and traditional Chinese medicine theory. She currently serves as a standing council member of the Chinese National Association of Ethnic Medicine's Branch on Dosage and Efficacy Research of Prescription Drugs, a committee member of the Medical Quality Excellence Committee of the China Pharmaceutical Quality Management Association, a member of the Psychosomatic Disease Pharmacotherapy Group of the Psychosomatic Medicine Branch of the Suzhou Medical Association, a member and secretary of the Humanistic Pharmacy Committee of the Suzhou Pharmaceutical Association, and a member and secretary of the Youth Committee of the Chronic Disease Prevention and Treatment Pharmacy Committee of the Suzhou Association of Integrative Medicine. She has led nine provincial and municipal-level research projects. She has received one second prize for the Jiangsu Medical New Technology Introduction Award, one second prize for the Jiangsu Pharmaceutical Association's Hospital Pharmacy Research Project, and one software copyright. She has published four SCI papers as the first or corresponding author (with the highest IF=15.3) and 13 papers in core journals of the Beijing Library. She has also co-authored four works published by People's Medical Publishing House.
Research Focus:
1. Clinical Pharmacy and Personalized Therapy;
2. Anticoagulant Drug Monitoring;
3. Effects and Mechanisms of Traditional Chinese Medicine in Preventing and Treating Inflammatory and Immune Diseases;
4. Relationship Between Gut Microbiota and Cardiac Injury
Selected Publications (* represents corresponding author):
1. Ding Y, Xue L, Qin Q, Huang H, Chen Y, Shen H, Hu Y, Chen Y, Miao L, Shen Z. Exploring the effects of renal and cardiac functions on the pharmacokinetics of vancomycin in patients undergoing cardiac surgery: a population pharmacokinetic analysis. Int J Clin Pharm. Published online January 21, 2026. doi:10.1007/s11096 -025-02077-w
2. Xue L, Ma G, Holford N, Qin Q, Ding Y, Hannam JA, Ding X, Fan H, Ji Z, Yang B, Shen H, Shen Z, Miao L. A Randomized Trial Comparing Standard of Care to Bayesian Warfarin Dose Individualization. Clin Pharmacol Ther, 2024, 115(6):1316-1325.
3. Ling Xue, Shan He, Rajeev K Singla, Qiong Qin, Yinglong Ding, Linsheng Liu,Xiaoliang Ding, Harbil Bediaga-Bañeres, Sonia Arrasate,Aliuska Durado-Sanchez, Yuzhen Zhang, Zhenya Shen, Bairong Shen, Liyan Miao, Humberto González-Díaz. Machine learning guided prediction of warfarin blood levels for personalized medicine based on clinical longitudinal data from cardiac surgery patients: a prospective observational study. Int J Surg,2024,110(10):6528-6540.
4. Chunge Zhang, Qi Wu, Yinhua Gong, Qiong Qin, Qiang Han, Zongqi Cheng, Zhaowei Yan. Biomimetic exosomal vesicles loaded with siRNA improves antitumor immune responses by inhibiting the secretion of tumor-derived exosome PD-L1. Int Immunopharmacol. 2024;129:111659.
5. Xue L, Ding Y, Qin Q, Liu L, Ding X, Zhou Y, Liu K, Singla RK, Shen K, Din AU, Zhang Y, Shen Z, Shen B, Miao L. Assessment of the impact of intravenous antibiotics treatment on gut microbiota in patients: Clinical data from pre-and post-cardiac surgery. Front Cell Infect. Microbiol, 2023, 12:1043971.
6. Xue L, Singla RK, Qin Q, Ding Y, Liu L, Ding X, Qu W, Huang C, Shen Z, Shen B, Miao L. Exploring the complex relationship between vitamin K, gut microbiota, and warfarin variability in cardiac surgery patients.Int J Surg, 2023,109(12): 3861-3871.
7. Xie C, Lin J, Qin Q, Zhu J. Efficacy and Safety of Ticagrelor in East Asian Patients with Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials. Anatol J Cardiol. 2022;26(6):434-441.
8. Wanqing Wang, Tao Xu, Qiong Qin, Liyan Miao, Jian an Bao, and Rong Chen. Effect of a Multidimensional Pharmaceutical Care Intervention on Inhalation Technique in Patients with Asthma and COPD. Canadian Respiratory Journal, 2020,2020:8572636.
